179 related articles for article (PubMed ID: 9559679)
1. Conversion of Amadori product of Maillard reaction to Nepsilon-(carboxymethyl)lysine in alkaline condition.
Nagai R; Ikeda K; Kawasaki Y; Sano H; Yoshida M; Araki T; Ueda S; Horiuchi S
FEBS Lett; 1998 Mar; 425(2):355-60. PubMed ID: 9559679
[TBL] [Abstract][Full Text] [Related]
2. Conversion of Amadori products of the Maillard reaction to N(epsilon)-(carboxymethyl)lysine by short-term heating: possible detection of artifacts by immunohistochemistry.
Miki Hayashi C; Nagai R; Miyazaki K; Hayase F; Araki T; Ono T; Horiuchi S
Lab Invest; 2002 Jun; 82(6):795-808. PubMed ID: 12065691
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product.
Nagai R; Ikeda K; Higashi T; Sano H; Jinnouchi Y; Araki T; Horiuchi S
Biochem Biophys Res Commun; 1997 May; 234(1):167-72. PubMed ID: 9168983
[TBL] [Abstract][Full Text] [Related]
4. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.
Ikeda K; Higashi T; Sano H; Jinnouchi Y; Yoshida M; Araki T; Ueda S; Horiuchi S
Biochemistry; 1996 Jun; 35(24):8075-83. PubMed ID: 8672512
[TBL] [Abstract][Full Text] [Related]
5. Natural compounds containing a catechol group enhance the formation of Nε-(carboxymethyl)lysine of the Maillard reaction.
Fujiwara Y; Kiyota N; Tsurushima K; Yoshitomi M; Mera K; Sakashita N; Takeya M; Ikeda T; Araki T; Nohara T; Nagai R
Free Radic Biol Med; 2011 Apr; 50(7):883-91. PubMed ID: 21195168
[TBL] [Abstract][Full Text] [Related]
6. Evolution of protein bound Maillard reaction end-products and free Amadori compounds in low lactose milk in presence of fructosamine oxidase I.
Troise AD; Buonanno M; Fiore A; Monti SM; Fogliano V
Food Chem; 2016 Dec; 212():722-9. PubMed ID: 27374589
[TBL] [Abstract][Full Text] [Related]
7. The quantification of free Amadori compounds and amino acids allows to model the bound Maillard reaction products formation in soybean products.
Troise AD; Wiltafsky M; Fogliano V; Vitaglione P
Food Chem; 2018 May; 247():29-38. PubMed ID: 29277225
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients.
Vay D; Vidali M; Allochis G; Cusaro C; Rolla R; Mottaran E; Bellomo G; Albano E
Diabetologia; 2000 Nov; 43(11):1385-8. PubMed ID: 11126407
[TBL] [Abstract][Full Text] [Related]
9. Hypochlorous acid generates N epsilon-(carboxymethyl)lysine from Amadori products.
Mera K; Nagai R; Haraguchi N; Fujiwara Y; Araki T; Sakata N; Otagiri M
Free Radic Res; 2007 Jun; 41(6):713-8. PubMed ID: 17516244
[TBL] [Abstract][Full Text] [Related]
10. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
[TBL] [Abstract][Full Text] [Related]
11. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.
Reddy S; Bichler J; Wells-Knecht KJ; Thorpe SR; Baynes JW
Biochemistry; 1995 Aug; 34(34):10872-8. PubMed ID: 7662668
[TBL] [Abstract][Full Text] [Related]
12. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions.
Fu MX; Requena JR; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
J Biol Chem; 1996 Apr; 271(17):9982-6. PubMed ID: 8626637
[TBL] [Abstract][Full Text] [Related]
13. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction.
Shibayama R; Araki N; Nagai R; Horiuchi S
Diabetes; 1999 Sep; 48(9):1842-9. PubMed ID: 10480617
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction.
Glomb MA; Monnier VM
J Biol Chem; 1995 Apr; 270(17):10017-26. PubMed ID: 7730303
[TBL] [Abstract][Full Text] [Related]
16. Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein.
Ahmed MU; Thorpe SR; Baynes JW
J Biol Chem; 1986 Apr; 261(11):4889-94. PubMed ID: 3082871
[TBL] [Abstract][Full Text] [Related]
17. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins.
Fu S; Fu MX; Baynes JW; Thorpe SR; Dean RT
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):233-9. PubMed ID: 9461515
[TBL] [Abstract][Full Text] [Related]
18. Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products.
Mera K; Nagai M; Brock JW; Fujiwara Y; Murata T; Maruyama T; Baynes JW; Otagiri M; Nagai R
J Immunol Methods; 2008 May; 334(1-2):82-90. PubMed ID: 18353354
[TBL] [Abstract][Full Text] [Related]
19. Aminoguanidine inhibits protein browning without extensive Amadori carbonyl blocking.
Requena JR; Vidal P; Cabezas-Cerrato J
Diabetes Res Clin Pract; 1993 Jan; 19(1):23-30. PubMed ID: 8472617
[TBL] [Abstract][Full Text] [Related]
20. Development of Diagnostic Fragment Ion Library for Glycated Peptides of Human Serum Albumin: Targeted Quantification in Prediabetic, Diabetic, and Microalbuminuria Plasma by Parallel Reaction Monitoring, SWATH, and MSE.
Korwar AM; Vannuruswamy G; Jagadeeshaprasad MG; Jayaramaiah RH; Bhat S; Regin BS; Ramaswamy S; Giri AP; Mohan V; Balasubramanyam M; Kulkarni MJ
Mol Cell Proteomics; 2015 Aug; 14(8):2150-9. PubMed ID: 26023067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
